Cronin previously served as chief brand & corporate affairs officer at Moderna. Medtronic says she brings experience in global brand strategy, consumer marketing, corporate communications, public affairs and employee engagement.
This marks yet another significant leadership move for Medtronic Diabetes, which last month named Laura Endres as the new head of Americas.
Prior to her time at Moderna, Cronin served as global CEO of Ogilvy Health, part of WPP. There, she oversaw a diverse portfolio spanning pharmaceuticals, consumer health, devices and wellness. She also served on Ogilvy’s global executive committee. Medtronic says her leadership supported breakthrough campaigns for clients including Pfizer, Merck, Boehringer Ingelheim and Bristol-Myers Squibb.
Other leadership roles include time spent at Porter Novelli and Ogilvy PR Worldwide. Cronin began her professional career conducting neuroscience research at Cornell University Medical College.
“I’m absolutely thrilled to embark on this new chapter as chief marketing officer at Medtronic Diabetes, leading a dynamic team to shape the future of diabetes technology,” said Cronin. “The chance to elevate innovation that truly changes lives is both humbling and energizing. I can’t wait to share how we’re transforming care for millions around the world.”
Medtronic Diabetes has hit a number of recent milestones, including FDA approval of the Simplera Sync continuous glucose monitor (CGM) for use with the MiniMed 780G and the FDA submission of an interoperable insulin pump that would pair with Abbott’s CGMs.
